| n | Percentage (95% CI a ) | Odds ratio b (95% CI a ) | Odds ratio p-value |
---|---|---|---|---|
Anti-Tat humoral responses | Â | Â | Â | Â |
Vaccinees | 155 | 79 (73–86) |  |  |
Tat 7.5 μg, 3x | 40 | 70 (56–84) | reference |  |
Tat 7.5 μg, 5x | 40 | 70 (56–84) | 1.0 (0.5; 2.2) | 1.0000 |
Tat 30 μg, 3x | 38 | 92 (84–100) | 5.0 (1.8; 13.9) | 0.0021 |
Tat 30 μg, 5x | 37 | 86 (75–97) | 2.7 (1.1; 6.7) | 0.0272 |
Anti-Tat cellular responses | Â | Â | Â | Â |
Vaccinees | 155 | 84 (79–90) |  |  |
Tat 7.5 μg, 3x | 40 | 80 (68–92) | reference |  |
Tat 7.5 μg, 5x | 40 | 88 (77–98) | 1.7 (0.7; 4.4) | 0.3253 |
Tat 30 μg, 3x | 38 | 87 (76–98) | 1.6 (0.6; 4.2) | 0.2900 |
Tat 30 μg, 5x | 37 | 84 (72–96) | 1.3 (0.5; 3.2) | 0.5758 |
Comparison among groups | Â | Â | Â | 0.6697c |